DE202004019220U1 - Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut - Google Patents

Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut Download PDF

Info

Publication number
DE202004019220U1
DE202004019220U1 DE202004019220U DE202004019220U DE202004019220U1 DE 202004019220 U1 DE202004019220 U1 DE 202004019220U1 DE 202004019220 U DE202004019220 U DE 202004019220U DE 202004019220 U DE202004019220 U DE 202004019220U DE 202004019220 U1 DE202004019220 U1 DE 202004019220U1
Authority
DE
Germany
Prior art keywords
mucosa
dermatological diseases
anhydrous base
treating dermatological
adheres
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202004019220U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE202004019220U priority Critical patent/DE202004019220U1/de
Publication of DE202004019220U1 publication Critical patent/DE202004019220U1/de
Priority to DE102005059420A priority patent/DE102005059420B4/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DE202004019220U 2004-12-09 2004-12-09 Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut Expired - Lifetime DE202004019220U1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE202004019220U DE202004019220U1 (de) 2004-12-09 2004-12-09 Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut
DE102005059420A DE102005059420B4 (de) 2004-12-09 2005-12-07 Verwendung einer Hypromellose enthaltende zu einer Buccaltablette gepressten Haftpaste zur Behandlung lokaler Erkrankungen der Mundschleimhaut

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202004019220U DE202004019220U1 (de) 2004-12-09 2004-12-09 Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut

Publications (1)

Publication Number Publication Date
DE202004019220U1 true DE202004019220U1 (de) 2005-03-17

Family

ID=34353739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202004019220U Expired - Lifetime DE202004019220U1 (de) 2004-12-09 2004-12-09 Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut

Country Status (1)

Country Link
DE (1) DE202004019220U1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762226A3 (de) * 2005-07-22 2007-05-09 Mipharm S.P.A. Topische Gelformulierung mit den Wirkstoffen Acyclovir und Lidocain
DE102015113543A1 (de) * 2015-08-17 2017-02-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung des Hals-/Rachenraums

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762226A3 (de) * 2005-07-22 2007-05-09 Mipharm S.P.A. Topische Gelformulierung mit den Wirkstoffen Acyclovir und Lidocain
DE102015113543A1 (de) * 2015-08-17 2017-02-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung des Hals-/Rachenraums

Similar Documents

Publication Publication Date Title
AR042705A1 (es) Derivados de pirazol modulador de ppar
IL172705A (en) Use of 4 - (2-chloroethyl) -1 - ((cyclohexan-1-yl) hydroxymethyl) -5-methyl-6-oxa-2-azabicyclo [0.2.3] Heftan-7,3-discussion Medicines
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
NO20034684D0 (no) Innretning for administrering av midler gjennom stratum corcum
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
CY1108548T1 (el) Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
MXPA05003041A (es) Dispositivo medico para dispensar medicamentos.
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
MX2009008228A (es) N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide.
WO2008101907A3 (en) N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
RS50593B (sr) Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
ATE432710T1 (de) Pharmazeutische zusammensetzungen, die diaminooxidase enthalten
FR2887150B1 (fr) Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
WO2006088945A3 (en) Granulysin peptides and methods of use thereof
ATE339224T1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
IS7912A (is) Notkun dókósahexensýru sem virks efnis til að meðhöndla fitukyrking
DE202004019220U1 (de) Paste zur Behandlung dermatologischer Erkrankungen der Mundschleimhaut
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
AR054361A1 (es) Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
DE502005001398D1 (de) Hautpflegeprodukt enthaltend Ursolsäure und Ginkgo-Extrakt

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20050421

R163 Identified publications notified

Effective date: 20050825

R150 Utility model maintained after payment of first maintenance fee after three years

Effective date: 20080505

R151 Utility model maintained after payment of second maintenance fee after six years

Effective date: 20110304

R158 Lapse of ip right after 8 years

Effective date: 20130702